Tricia Nelson, NP
Nurse Practitioner · Rome, GANPI 1972025955
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 31 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 11 manufacturers reported payments, led by Collegium Pharmaceutical, Inc. at 31.0% of the total. Reporting peaked in 2022 at $229 and has fallen 54.1% since, to $105 in 2024.
Across 31 payments — averaging $15.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Collegium Pharmaceutical, Inc.$150
- Boston Scientific$96
- Medtronic$49
- Kowa Pharmaceuticals America, Inc.$38
- Tersera Therapeutics LLC$31
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$30
- plus $91 from 5 others
What the payments were for
- Food & beverage$485100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$485 in reported general payments places this provider in the 65th percentile of 3,328 nurse practitioner providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 41 | $408 |
| Cephalexin | 49 | $388 |
| Ondansetron OdtOndansetron | 37 | $347 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 13 | $181 |
| Methylprednisolone | 21 | $150 |
| Azithromycin | 20 | $114 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 25 | $98 |
| Ciprofloxacin Hcl | 13 | $86 |
| Diclofenac Sodium | 17 | $76 |
| Methocarbamol | 19 | $45 |
| Fluconazole | 13 | $44 |
| Prednisone | 16 | $27 |
| Levofloxacin | 11 | $27 |
| Diazepam | 11 | $24 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Rome
- Tricia CollinsRome$17K
- Amie GreenRome$12K
- Inga BennettRome$11K
- Victor CzerkasijDalton$505K
- Kennon Mc CollumStockbridge$364K
- Tajuana BradleyJohns Creek$256K
- Jessica AdkinsSavannah$226K
- Janice McAlisterAtlanta$221K
- Laura ElledgeAtlanta$177K
- Afsha HussainiKennesaw$122K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.